Pulmonary actinomycosis coexisting with intestinal tuberculosis as a complication of adalimumab treatment for Crohn's disease

Acta Gastroenterol Belg. 2017 Oct-Dec;80(4):544-546.

Authors

I Aleric^{1

2}, D Katalinic¹, A Vcev¹, M Brinar³

Affiliations

¹ Department of Internal Medicine, School of Medicine, J. J. Strossmayer University of Osijek, Osijek, Croatia.
² Department of Pulmonary Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
³ Department of Gastroenterology, University Hospital Centre Zagreb, Zagreb, Croatia.

PMID: 29560655

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Actinomycosis / diagnosis*
Adalimumab / adverse effects*
Anti-Inflammatory Agents / adverse effects*
Crohn Disease / drug therapy*
Diagnosis, Differential
Humans
Lung Diseases / diagnosis*
Lung Diseases / microbiology*
Male
Opportunistic Infections / diagnosis*
Tuberculosis, Gastrointestinal / diagnosis*
Young Adult

Substances

Anti-Inflammatory Agents
Adalimumab